Active ingredient
- sofosbuvir
- velpatasvir
- voxilaprevir
Legal Category
POM: Prescription only medicine
POM: Prescription only medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: EU/1/17/1223/001 .
Vosevi 400 mg/100 mg/100 mg film coated tablets
Package leaflet: Information for the user
Vosevi 400 mg/100 mg/100 mg film-coated tablets
sofosbuvir/velpatasvir/voxilaprevir
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
What is in this leaflet
1. What Vosevi is and what it is used for
2. What you need to know before you take Vosevi
3. How to take Vosevi
4. Possible side effects
5. How to store Vosevi
6. Contents of the pack and other information
If Vosevi has been prescribed for your child, please note that all the information in this leaflet is addressed to your child (in this case please read “your child” instead of “you”).
1. What Vosevi is and what it is used for
Vosevi is a medicine that contains the active substances sofosbuvir, velpatasvir and voxilaprevir in a single tablet. It is given to treat a chronic (long-term) viral infection of the liver called hepatitis C in patients aged 12 years and older and weighing at least 30 kg.
The active substances in this medicine work together by blocking three different proteins that the hepatitis C virus needs to grow and reproduce itself, causing the infection to be eliminated from the body.
2. What you need to know before you take Vosevi
Do not take Vosevi
If you are allergic to sofosbuvir, velpatasvir, voxilaprevir or any of the other ingredients of this medicine (listed in section 6 of this leaflet).
Warnings and precautions
Talk to your doctor if you:
Talk to your doctor or pharmacist before taking Vosevi if:
Tell your doctor immediately if you currently take, or have taken in the last months, any medicines for heart problems and during treatment you experience:
Blood tests
Your doctor will test your blood before, during and after your treatment with Vosevi. This is so that:
Children and adolescents
Do not give this medicine to children under 12 years of age and weighing less than 30 kg. The use of Vosevi in these patients has not yet been studied.
Other medicines and Vosevi
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
If you are not sure talk to your doctor or pharmacist.
Some medicines must not be taken with Vosevi. Taking Vosevi with any of these may stop your medicines from working properly, or make any side effects worse:
Tell your doctor or pharmacist if you are taking any of the medicines below:
Taking Vosevi with any of these may stop your medicines from working properly, or make any side effects worse. Your doctor may need to give you a different medicine or adjust the dose of medicine you are taking.
These medicines can decrease the amount of Vosevi in your blood. If you are taking one of these medicines your doctor will either give you a different medicine for stomach ulcers, heartburn or acid reflux, or recommend how and when you take that medicine.
Pregnancy, breast-feeding and fertility
If you are pregnant, think you may be pregnant, are breast-feeding your baby, or are planning to have a baby ask your doctor for advice before taking this medicine.
Pregnancy
Vosevi is not recommended during pregnancy. The effects of Vosevi during pregnancy are not known.
Breast-feeding
Do not breast-feed during treatment with Vosevi. Some of the active substances of Vosevi may pass into human breast milk.
Driving and using machines
Vosevi should not affect your ability to drive or use any tools or machinery.
Vosevi contains lactose
3. How to take Vosevi
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Recommended dose
The recommended dose of Vosevi is one 400 mg/100 mg/100 mg tablet or two 200 mg/50 mg/50 mg tablets, taken once a day for 8 or 12 weeks.
Take Vosevi as advised by your doctor.
Swallow the tablet(s) whole with food. Do not chew, crush or split the tablet as it has a very bitter taste.
Kidney problems
Tell your doctor if you have kidney problems or if you are on kidney dialysis, since Vosevi has not been fully tested in patients with severe kidney problems.
Liver problems
Vosevi should not be used if you have moderate or severe liver problems.
If you are taking an antacid, take it at least 4 hours before or at least 4 hours after Vosevi.
If you are sick (vomit) after taking Vosevi it may affect the amount of Vosevi in your blood. This may make Vosevi work less well.
If you take more Vosevi than you should
If you accidentally take more than the recommended dose of Vosevi you may be at increased risk of side effects with this medicine (see section 4 Possible side effects).
Contact your doctor or nearest emergency department immediately for advice. Keep the tablet bottle with you so that you can easily describe what you have taken.
If you forget to take Vosevi
It is important not to miss a dose of this medicine.
If you do miss a dose, work out how long it is since you last took your Vosevi:
Do not stop taking Vosevi
Do not stop taking this medicine unless your doctor tells you to. It is very important that you complete the full course of treatment to give the medicine the best chance to treat your hepatitis C virus infection.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine may cause side effects, although not everybody gets them.
Some side effects could be serious.
Stop taking Vosevi and seek medical help immediately if you experience any of the following symptoms:
Other side effects that may occur
Very common side effects
(may affect more than 1 in 10 people)
Common side effects
(may affect up to 1 in 10 people)
Uncommon side effects
(may affect up to 1 in 100 people)
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store
By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Vosevi
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the bottle and carton after “EXP”. The expiry date refers to the last day of that month.
This medicine does not require any special temperature storage conditions. Store in the original package in order to protect from moisture. Keep the bottle tightly closed.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Vosevi contains
What Vosevi looks like and contents of the pack
Vosevi 400 mg/100 mg/100 mg film-coated tablets are beige, capsule-shaped tablets debossed with “GSI” on one side and “3” on the other side. The tablet is 20 mm long and 10 mm wide.
The tablets are packed in plastic bottles with child resistant caps. Each bottle contains a silica gel desiccant (drying agent) that must be kept in the bottle to help protect your tablets. The silica gel desiccant is contained in a separate sachet or canister and should not be swallowed.
The following pack size is available:
Marketing Authorisation Holder
Manufacturer
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
This leaflet was last revised in 11/2021
280 High Holborn, London, WC1V 7EE, UK
+353 214 825 999 (Ireland)
+44 (0)203 681 4681
+44 (0)203 681 4500
08000 113 700 (UK)
+353 1 291 3580 (Ireland)